張牧新醫師詳細介紹

國立陽明大學臨床醫學研究所 博士

國立成功大學醫學系醫學士

2015-迄今臺北榮民總醫院腫瘤醫學部 腫瘤內科主治醫師

2018-迄今國立陽明交通大學 醫學院副教授

2008-2015臺北榮民總醫院內科部血液腫瘤科主治醫師

2002-2008臺北榮民總醫院內科部血液腫瘤科住院醫師

2013-2018國立陽明交通大學醫學院助理教授

2015-2016史丹佛大學Department of Chemical and Systems Biology訪問學者

一般腫瘤內科學、頭頸癌、鼻咽癌、泌尿系統癌症、臨床試驗、新藥開發

內科專科醫師、腫瘤科專科醫師、安寧緩和專科醫師、頭頸部腫瘤醫學專科醫師

Chang PM, Chen CH, Yeh CC, Lu HJ, Liu TT, Chen MH, Liu CY, Wu ATH, Yang MH, Tai SK, Mochly-Rosen D*, Huang CF*.  Transcriptome Analysis and Prognosis of ALDH Isoforms in Human Cancer. Sci Rep 2018 Feb; 8(1): 2713. (IF: 4.259; Multidisciplinary Sciences 10/64)

Chang PM, Lu HJ, Wang LW, Tai SK, Chen MH, Chu PY*, Yang MH*.  Effectiveness of Incorporating Cetuximab into Docetaxel/Cisplatin/Fluorouracil Induction Chemotherapy and Chemoradiotherapy for Inoperable Squamous Cell Carcinoma of the Oral Cavity: A Phase II Study. Head Neck 2017 Jul; 39(7): 1333-42. Epub 2017 Apr. (IF: 3.376; Otorhinolaryngology 1/42; Surgery 34/196)

Lu HJ, Mu-Hsin Chang P*.  How to Treat Recurrent/Metastatic Head and Neck Cancer: the Economic Issue in Real-World Practice. Curr Med Res Opin 2017 Apr; 33(4): 779-80. Epub 2017 Jan. (IF: 2.757; Medicine, General & Internal 33/154; Medicine, Research & Experimental 53/128)

Lu HJ, Yang CC, Wang LW, Chu PY, Tai SK, Chen MH, Yang MH, Chang PM.  Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer. Biomed Res Int 2015 Feb; 2015(): 307576. (IF: 2.134; Biotechnology & Applied Microbiology 82/161; Medicine, Research & Experimental 72/124)

Chen WC, Chu PY, Lee YT, Lu WB, Liu CY, Chang PM*, Yang MH*.  Pembrolizumab for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in an Asian Population. Medicine (Baltimore) 2017 Dec; 96(52): e9519. (IF: 1.803; Medicine, General & Internal 58/154)

Chang PM, Cheng CT, Wu RC, Chung YH, Chiang KC, Yeh TS, Liu CY, Chen MH, Chen MH*, Yeh CN*.  Nab-Paclitaxel is Effective against Intrahepatic Cholangiocarcinoma via Disruption of Desmoplastic Stroma. Oncol Lett 2018 Jul; 16(1): 566-72. Epub 2018 May. (IF: 1.664; Oncology 193/222)